Ferroglobe (5FG) Q2 2026 Earnings Report

The quarter showed clear operational and financial improvement: sequential growth in shipments and revenue, a meaningful rise in adjusted EBITDA and a swing to positive free cash flow, plus deleveraging and strategic progress on critical materials and trade protections. However, significant headwinds remain — persistent price pressure from low-cost imports (particularly from China and Angola), uneven effectiveness of EU safeguards, regional energy cost disadvantages in Europe, and some reliance on non-recurring benefits. The company has several actionable strategic opportunities (ferroalloys, magnesium, Venezuelan capacity optionality) that could be value-accretive if regulatory approvals and project economics hold, but execution and external market risks are meaningful.

Management guided that they expect initial commercial activity on the critical‑materials plan before year‑end, industrial‑scale tests of additional ferroalloys later this year, and a U.S. decision on the Venezuela restart permit (four low‑cost furnaces, 120,000 tpa) before the end of Q3; they highlighted market opportunities such as North American ferromolybdenum demand of ~8,000 tpa (~$42,000/ton → >$300M/year) and magnesium demand of ~60,000 tpa (~$7,500/ton → ~$450M/year), noting a 20,000‑tpa magnesium plant would cost ~$180–200M pre‑subsidy. Management expects H2 improvement from the finalized U.S. silicon case and potential EU antidumping action, stable manganese volumes (Q2 index +~10%, ~+25% since safeguards), continued working‑capital release (~$15M in H2), no immediate buybacks, Q2 CapEx of $17M as the year high, and near‑term benefits to pricing and demand if trade measures progress.